Fig. 1.
Fig. 1. In vitro NK cell–mediated cytotoxicity levels of MNCs. / In vitro NK cell–mediated cytotoxicity levels of MNCs from G-CSF–mobilized (n = 98) or nonmobilized steady-state (n = 28) donor blood stem cell harvests against K562 (panel A) and Raji (panel B) tumor target cells by means of 51Cr release assay. Values represent mean percentages of specific cytotoxicity ± SEM from different samples. (For effector-to-target [E/T] ratios of 12.5:1, P = .005; 25:1, P = .0001; 50:1,P = .007; 100:1 P = .05.) ● indicates nonmobilized donors (n = 28); ▵, G-CSF mobilized donors (n = 104).

In vitro NK cell–mediated cytotoxicity levels of MNCs.

In vitro NK cell–mediated cytotoxicity levels of MNCs from G-CSF–mobilized (n = 98) or nonmobilized steady-state (n = 28) donor blood stem cell harvests against K562 (panel A) and Raji (panel B) tumor target cells by means of 51Cr release assay. Values represent mean percentages of specific cytotoxicity ± SEM from different samples. (For effector-to-target [E/T] ratios of 12.5:1, P = .005; 25:1, P = .0001; 50:1,P = .007; 100:1 P = .05.) ● indicates nonmobilized donors (n = 28); ▵, G-CSF mobilized donors (n = 104).

Close Modal

or Create an Account

Close Modal
Close Modal